ProstateNext is a genetic test that provides your healthcare providers with the tools necessary to manage and identify your risk for hereditary prostate cancer. The test looks at 14 different genes, including BRCA1 and BRCA2 (known as breast cancer predisposition genes). These genes, when mutated, have been shown to be associated with a 15% lifetime risk of developing prostate cancer, which is significantly higher than average risk men without the mutation.
The results of the ProstateNext text can help your healthcare provider determine your hereditary cancer risk, and along with other risk factors and PCMs, can aid in the development of a customized monitoring or diagnostic plan based upon your results.
Below are several resources designed to help patients and their family better understand how ProstateNext is used in a clinical setting, including a video as well as downloadable brochures.